XNAS: SPRY
ARS Pharma Inc Live Stock Price Today, Share Analysis and Chart
about
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intra...
Read More
5.91
-0.25
(-4.06%)
1.3M
XNAS Volume
XNAS 10 Aug, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for ARS Pharma Inc is on 13 Aug 2026 for the purpose of ARS Pharmaceuticals Inc Second Quarter Earnings Result for 2026
See details
Low Financial Strength
Expensive Valuation
Technically Bearish
Weak Stock
These stocks have poor scores across the board. Investors should be very cautious with these stocks
View Similar
Embed DVM
ARS Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..